Abstract
We have developed a low-cost and minimally-invasive MRS CDE combined procedure to diagnose routinely low grade rejection, allowing to eliminate systematic biopsies after the first year and to reduce the number of biopsies to the minimum required by the occurrence of immunological and or functional perturbations. The MRS CDE approach is also used to finetune the immunosuppressive treatment.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
